Effects of Combined Treatment of Ziyedan Capsules and Tenofovir Alafenamide Fumarate Tablets on Liver Function,Liver Fibrosis and Serum M-CSF,CTGF and CHI3L1 in Patients with Chronic Hepatitis B
Objective:To observe the effects of combined treatment of ziyedan capsules and tenofovir alafenamide fumarate tablets on liver function,liver fibrosis and serum macrophage colony-stimulating factor(M-CSF),connective tissue growth factor(CTGF)and chitinase 3-like protein 1(CHI3L1)in patients with chronic hepatitis B(CHB).Methods:138 CHB patients were divided into control group(treated with tenofovir alafenamide fumarate tablets)and study group(combined treatment with ziyedan capsules on the basis of control group)by random number table method,69 cases in each group.The efficacy,liver function indexes,serum M-CSF,CTGF,CHI3L1 levels,liver fibrosis indexes and incidence of adverse reactions were compared between two groups.Results:The total clinical effective rate in study group was higher than that in control group(P<0.05).Alanine aminotransferase(ALT),M-CSF,aspartate amino-transferase(AST),type Ⅲ procollagen(PC-Ⅲ),CTGF,hyaluronic acid(HA),total bilirubin(TBiL),type Ⅳ collagen(Ⅳ-C),CHI3L1 and laminin(LN)in study group were lower than those in control group after treatment(P<0.05).There was no difference in the inci-dence of adverse reactions between two groups(P>0.05).Conclusion:The combination of ziyedan capsules and tenofovir alafenamide fumarate tablets in the treatment of CHB patients,which can effectively improve the liver function,the degree of liver fibrosis,the levels of serum M-CSF,CTGF and CHI3L1.
Ziyedan capsulesTenofovir alafenamide fumarate tabletsChronic hepatitis BLiver functionLiver fibrosisM-CSFCTGFCHI3L1